Skip to Content

Tykerb Side Effects

Generic Name: lapatinib

Note: This document contains side effect information about lapatinib. Some of the dosage forms listed on this page may not apply to the brand name Tykerb.

For the Consumer

Applies to lapatinib: oral tablet

Warning

Oral route (Tablet)

Hepatotoxicity, which may be fatal or severe, has been observed in clinical trials and postmarketing experience. Causality of the deaths is uncertain.

Side effects requiring immediate medical attention

Along with its needed effects, lapatinib (the active ingredient contained in Tykerb) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking lapatinib:

More common

  • Cough
  • diarrhea
  • difficult or labored breathing
  • itching, skin rash
  • loosening of the fingernails
  • nosebleed
  • redness or soreness around the fingernails
  • redness, swelling, or pain of the skin
  • scaling of the skin on the hands and feet
  • tightness in the chest
  • tingling of the hands and feet ulceration of the skin
  • unusual tiredness or weakness

Rare

  • Chest pain
  • decreased urine output
  • dilated neck veins
  • extreme tiredness or weakness
  • irregular breathing
  • irregular heartbeat
  • swelling of the face, fingers, feet, or lower legs
  • weight gain

Incidence not known

  • Blistering, peeling, or loosening of the skin
  • chest discomfort
  • chills
  • clay-colored stools
  • dark urine
  • decreased appetite
  • difficulty with swallowing
  • dizziness
  • fainting
  • fast heartbeat
  • fever
  • headache
  • hives
  • irregular or slow heart rate
  • loss of appetite
  • nausea
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • red skin lesions, often with a purple center
  • red, irritated eyes
  • sore throat
  • sores, ulcers, or white spots in the mouth or on the lips
  • stomach pain or tenderness
  • swelling of the feet or lower legs
  • vomiting
  • yellow eyes or skin

Side effects not requiring immediate medical attention

Some side effects of lapatinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Back pain
  • belching
  • cracked lips
  • diarrhea (mild)
  • difficulty in moving
  • discoloration of the fingernails or toenails
  • dry skin
  • heartburn
  • indigestion
  • lack or loss of strength
  • muscle pain or stiffness
  • pain in the arms or legs
  • stomach discomfort or upset
  • swelling or inflammation of the mouth
  • thinning of hair or hair loss
  • trouble sleeping

For Healthcare Professionals

Applies to lapatinib: oral tablet

Gastrointestinal

Very common (10% or more): Diarrhea (77%), nausea (44%), vomiting (26%), stomatitis (14%), dyspepsia (11%), constipation, abdominal pain[Ref]

Hematologic

Very common (10% or more): Neutropenia (77%), hemoglobin lab abnormality (56%), leukopenia (53%), anemia (23%), neutrophils lab abnormality (22%), platelets lab abnormality (18%), decreased hemoglobin (10%)[Ref]

Dermatologic

Very common (10% or more): Rash (including dermatitis acneiform, 59%), Palmar-plantar erythrodysesthesia (53%), alopecia (13%), dry skin (13%), pruritus (12%), nail disorders (including paronychia, 11%)

Frequency not reported: Serious cutaneous reactions[Ref]

Hepatic

Very common (10% or more): AST lab abnormality (53%), ALT lab abnormality (46%), total bilirubin lab abnormality (45%), increased ALT (11%), hyperbilirubinemia

Common (1% to 10%): Hepatotoxicity[Ref]

Metabolic

Very common (10% or more): Decreased appetite (32%), anorexia (11%)[Ref]

Other

Very common (10% or more): Fatigue (22%), mucosal inflammation (15%), asthenia[Ref]

Musculoskeletal

Very common (10% or more): Myalgia (14%), pain in extremity (12%), back pain (11%), arthralgia[Ref]

Respiratory

Very common (10% or more): Dyspnea (12%), cough (10%), epistaxis

Uncommon (0.1% to 1%): Interstitial lung disease/pneumonitis[Ref]

Psychiatric

Very common (10% or more): Insomnia (10%)[Ref]

Cardiovascular

Very common (10% or more): Hot flush

Common (1% to 10%): Decreased left ventricular ejection fraction[Ref]

Nervous system

Very common (10% or more): Peripheral neuropathy

Common (1% to 10%): Headache[Ref]

Hypersensitivity

Rare (less than 0.1%): Hypersensitivity reactions (including anaphylaxis)[Ref]

References

1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. Cerner Multum, Inc. "Australian Product Information." O 0

3. "Product Information. Tykerb (lapatinib)." Novartis Pharmaceuticals, East Hanover, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.